The Pisa syndrome (Pleurothotonus) during antidepressant therapy

Biological Psychiatry

Volumn 41, Issue 2, 1997, Pages 234-236

  Suzuki, Toshihito ^b   Kurita, Hirofumi ^b   Hori, Takafumi ^b   Sasaki, Megumi ^b   Baba, Atsuomi ^b   Shiraishi, Hiroyasu ^b   Piletz, John E ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

anticholinergic drug; antidepressants; dopamine; noradrenaline; Pisa syndrome; serotonin

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; IMIPRAMINE; MAPROTILINE; NORTRIPTYLINE;

ADULT; ARTICLE; BODY POSTURE; CASE REPORT; DEPRESSION; DYSTONIA; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

AMITRIPTYLINE; ANTIDEPRESSIVE AGENTS; BIPERIDEN; DEPRESSIVE DISORDER; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; DYSKINESIA, DRUG-INDUCED; HUMANS; IMIPRAMINE; MALE; MAPROTILINE; MIDDLE AGED; MUSCULOSKELETAL EQUILIBRIUM; NORTRIPTYLINE; ORIENTATION; POSTURE;

EID: 0031047425     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(96)00405-2     Document Type: Article

References (22)

1. Amore M, Cerisoli M, Campanile S, Campanile A (1988): Pisa syndrome. Report of case. Ital J Neural Sci 9:273-274.
2. Arya DK (1994): Extrapyramidal symptoms with selective serotonin reuptake inhibitors. Br J Psychiatry 165:728-733.
3. Bennett JP Jr (1994): Drugs for affective (mood) disorders. In Brody TM, Larner J, Minneman KP, Neu HC (eds), Human Pharmacology, Molecular to Clinical, 2nd ed. St. Louis: Mosby, pp 333-342.
4. Bleich A, Brown S, Kahn R (1988): The role of serotonin in schizophrenia. Schizophr Bull 14:297-315.
5. Bouchard RH, Pourcher E, Vincent P (1989): Fluoxetine and extrapyramidal side effects. Am J Psychiatry 146:1352-1353.
6. Burke RE, Fahn S, Jankovic J, et al (1982): Tardive dystonia: Late-onset and persistent dystonia caused by antipsychotic drugs. Neurology 32:1335-1346.
7. Casey DE (1993): Dopaminergic and serotonergic aspects of acute extrapyramidal syndromes. Psychopharmacol Ser 10: 101-110.
8. Chiu HFK, Li SWL, Lee S (1989): Pisa syndrome in a Chinese patient. Aust NZ J Psychiatry 23:127-128.
9. Dawling S, Crome P, Braithwaite R (1980): Pharmacokinetics of single oral doses of nortriptyline in depressed elderly hospital patients and young healthy volunteers. Clin Pharmacokinet 5:39-401.
10. Ekbom K, Lindholm H, Ljungberg L (1972): New dystonic syndrome associated with butyrophenone therapy. Z Neurol 202:94-103.
11. Guy N, Raps A, Assael M (1986): The Pisa syndrome during maintenance antipsychotic therapy. Am J Psychiatry 143:1492.
12. Kaplan HI, Sadock BJ, Grebb JA (1994): Kaplan and Sadock's Synopsis of Psychiatry, Behavioral Sciences, Clinical Psychiatry, 7th ed. Baltimore: Williams & Wilkins.
13. Povlsen UJ, Noring U, Lund LA (1986): Effects of serotonergic and anticholinergic drugs in haloperidol-induced dystonia in Cebus monkeys. Clin Neuropharmacol 9:84-90.
14. Remington GJ (1988): The Pisa syndrome: Possible role for serotonin and noradrenaline. J Clin Psychopharmacol 8:228-229.
15. Richelson E (1991): Biological basis of depression and therapeutic relevance. J Clin Psychiatry 52(6 suppl):4-10.
16. Saxena S (1986): Tardive dystonia and Pisa syndrome. Br J Psychiatry 149:524.
17. Suzuki T, Koizumi J, Moroji T, Sakuma K, Hori M, Hori T (1990): Clinical characteristics of the Pisa syndrome. Acta Psychiatr Scand 82:454-457.
18. Suzuki E, Kanba S, Nibuya M, et al (1992): Use of pimozide in the Pisa syndrome. Am J Psychiatry 149:1114-1115.
19. Tollefson GD (1991): Antidepressant treatment and side effect considerations. J Clin Psychiatry 52(5 Suppl):4-13.
20. Turk J, Lask B (1991): Pisa syndrome in an adolescent on neuroleptic medication. Br J Psychiatry 158:422-423.
21. Yassa R (1985): The Pisa syndrome: A report of two cases. Br J Psychiatry 146:93-95.
22. Yassa R, Nastase C, Cvejic J, Laberge G (1990): The Pisa syndrome (or pleurothotonus): Prevalence in a psychogeriatric population. Biol Psychiatry 29:942-945.